L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S)-1-carboxy-2-methylpropyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI) (220379-17-9)

Identification
Name:	L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S)-1-carboxy-2-methylpropyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
Synonyms:	BoletocrocinE
CAS:	220379-17-9
Molecular Formula:	C25H30 N2 O8
Molecular Structure:
Properties
Safety Data

Other Product

L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Glutamic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E)-14-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,14-dioxo-2,4,6,8,10,12-tetradecahexaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E)-12-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,12-dioxo-2,4,6,8,10-dodecapentaenyl]-(9CI)
2,4,6,8,10,12,14-Heptadecaheptaen-16-ynal,17- [(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexen- 1-yl]-2,6,11,15-tetramethyl-,(2E,4E,- 6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14-Hexadecaheptaenoicacid, 2,6,11,15-tetramethyl-16-oxo-, (2E,4E,6E,8E,10E,12E,14E)-
2-Butenoic acid,4-amino-4-oxo-,(2R,4R,5S,6R)-6-ethyltetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-2H-pyran-4-ylester, (2E)- (9CI)
2,4,6,8,10,12,14-Hexadecaheptaenediamide,N,N'-bis(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-, (2E,4E,6E,8E,10E,12E,14E)- (9CI)
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12,14-Pentadecaheptaenoic acid,15-(4-chloro-3-hydroxy-2-methylphenyl)-, methyl ester,(2E,4E,6E,8E,10E,12E,14E)-
(2E,4E,6E,8E,10E,12E,14E)-4,9,13,17,17-Pentamethyl-16,21-dioxo-2,4,6,8,10,12,14-docosaheptaenoic acid
2,4,6,8,10,14-Hexadecahexaenamide,13-hydroxy-N-[(1S)-2-methoxy-1-methylethyl]-2,10,12,14-tetramethyl-,(2E,4E,6E,8E,10E,12R,13R,14E)-
2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-[(1R)-2,6,6-trimethyl-2-cyclohexen-1-yl]-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2,4,6,8,10,12,14,16-Heptadecaoctaen-1-ol,2,6,11,15-tetramethyl-17-(2,3,4-trimethylphenyl)-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
2-Butenedioic acid,2-methyl-,1-[(2E,6E,10E,14E)-16-hydroxy-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]ester, (2E)- (9CI)
2,4,6,8,10,12,14-Pentadecaheptaenoic acid,15-(3-hydroxy-2-methylphenyl)-, methyl ester,(2E,4E,6E,8E,10E,12E,14E)-
b-D-Glucopyranose, 1-[hydrogen(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate],6'-ester with 2-b-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one(9CI)
2,4,6,8,10,12,14,16,18,20,22-Tricosaundecaenal,23-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-4,8,12,17,21-pentamethyl-,(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)- (9CI)
2,4,6,8,10,12,14-Hexadecaheptaenedial,(2E,4E,6E,8E,10E,12E,14E)-
2,4,6,8,10,12,14,16-Octadecaoctaene,(2E,4E,6E,8E,10E,12E,14E,16E)-